NS · Healthcare

Anthem Biosciences Ltd (ANTHEM)

Pharmaceuticals & Biotechnology

Anthem Biosciences Ltd (ANTHEM) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $434.20B, P/E ratio is 64.74, dividend yield is 0.26%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANTHEM

Market cap

$434.20B

P/E ratio

64.74

Dividend yield

0.26%

Anthem Biosciences Ltd (ANTHEM) — FAQ

What is Anthem Biosciences Ltd's market cap?

Anthem Biosciences Ltd (ANTHEM) has a reported market cap of $434.20B (data as of 2026-07-11).

What is ANTHEM's P/E ratio?

The price-to-earnings (P/E) ratio for Anthem Biosciences Ltd (ANTHEM) is 64.74 (data as of 2026-07-11).

Does Anthem Biosciences Ltd pay a dividend?

Anthem Biosciences Ltd (ANTHEM) shows a reported dividend yield of 0.26%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Anthem Biosciences Ltd in?

Anthem Biosciences Ltd (ANTHEM) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is ANTHEM listed on?

ANTHEM is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)